INVA
INVA
NASDAQ · Pharmaceuticals

Innoviva Inc

$22.88
+0.08 (+0.35%)
As of May 9, 1:33 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 1 9%
Sell 1 9%
Price Target
Analyst Price Target +71.2% upside
Low Target $23.99
Average Target $39.16
High Target $41.33
Current Price $22.88
Current
$22.88
Target
$39.16
$23.99 $39.16 avg $41.33
Scenario Analysis
Bear Case
$23.99
4.9%
Low target
Base Case
$39.16
+71.2%
Avg target
Bull Case
$41.33
+80.6%
High target
Risk/Reward
16.6x
Highly favorable
Price in Context
52-Week High
$25.15
-9.0% from high
52-Week Low
$16.52
+38.5% from low
Target vs 52W High
$39.16
+55.7% vs high
Next Earnings Report
May 13, 2026
2d
until earnings
EPS Est: $0.40
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%